<- Go Home
IMARA Inc.
As of February 23, 2023, IMARA Inc. was acquired by Enliven Therapeutics, Inc., in a reverse merger transaction. IMARA Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapeutics to treat patients suffering from serious diseases. The company was incorporated in 2016 and is based in Brookline, Massachusetts.
Market Cap
$165.8M
Volume
260.0K
Cash and Equivalents
$88.2M
EBITDA
-$33.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$25.28
52 Week Low
$3.90
Dividend
N/A
Price / Book Value
1.84
Price / Earnings
111.65
Price / Tangible Book Value
1.84
Enterprise Value
$77.6M
Enterprise Value / EBITDA
-2.31
Operating Income
-$34.3M
Return on Equity
1.69%
Return on Assets
-23.08
Cash and Short Term Investments
$88.2M
Debt
N/A
Equity
$90.1M
Revenue
N/A
Unlevered FCF
-$22.7M
Sector
Pharmaceuticals
Category
N/A